CEO: Michael R. McMullen

Sector: Health Technology

Exchange: New York Stock Exchange

Country: US

Description: Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment comprises activity providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.


Key numbers

Market Capitalization:30065616490
Shares Outstanding: 308777000
Float: 307009560
Next Earning Date:
TTm EPS: 2.2024
TTm Dividend Rate: 0.688
200 days moving average:83.15
50 days moving average: 92.12
One day percent Change: 1.63



2018-04-30, 2018-07-31, 2018-10-31, 2019-01-31,
2018-04-30, 2018-07-31, 2018-10-31, 2019-01-31,
2015-10-31, 2016-10-31, 2017-10-31, 2018-10-31,
2015-10-31, 2016-10-31, 2017-10-31, 2018-10-31,